Biotech · Private company
Dizal Pharmaceuticals
Track this companyFree. Adds Dizal Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials164 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- Pemetrexed+carboplatinPhase 3 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- sunvozertinibPhase 3 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- golidocitinibPhase 2 · Relapsed or Refractory Peripheral T Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- [14C]-AZD4205, single 50 mg oral dose administrated on day 1Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- [14C]-DZD9008Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- AZD4205Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- AZD4205 and carbamazepinePhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- AZD4205 and itraconazolePhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- DZD1516 mono therapy in Part A, DZD1516 in combination with trastuzumab and/or capecitabine in Part B, DZD1516 in combination with T-DM1 in Part CPhase 1 · Breast Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- DZD2269Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- DZD2269Phase 1 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- DZD6008Phase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- DZD8586Phase 1 · Lymphoma, Non-HodgkinClinicalTrials.gov · fetched Nov 12, 2026
- DZD9008Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- DZD9008Phase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- DZD9008 and carbamazepinePhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- DZD9008 and intraconazolePhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials16
- Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic LeukemiaPHASE2 · NOT_YET_RECRUITING · started Dec 31, 2026ClinicalTrials.gov NCT07682792 · fetched Nov 12, 2026
- A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)PHASE1 · RECRUITING · started May 13, 2025ClinicalTrials.gov NCT06905197 · fetched Nov 12, 2026
- DZD9008 PK Study in Hepatic Impairment SubjectsPHASE1 · COMPLETED · started Oct 17, 2023ClinicalTrials.gov NCT06084104 · fetched Nov 12, 2026
- DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaPHASE1 · COMPLETED · started May 15, 2023ClinicalTrials.gov NCT05824585 · fetched Nov 12, 2026
- A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 13, 2022ClinicalTrials.gov NCT05668988 · fetched Nov 12, 2026
- Drug-drug Interactions Between AZD4205 and Itraconazole/CarbamazepinePHASE1 · COMPLETED · started Jul 27, 2022ClinicalTrials.gov NCT05486949 · fetched Nov 12, 2026
- Drug-drug Interactions Between DZD9008 and Itraconazole/CarbamazepinePHASE1 · COMPLETED · started Jan 25, 2022ClinicalTrials.gov NCT05418582 · fetched Nov 12, 2026
- Pharmacokinetic and Mass Balance Study of Oral-Administrated [14C]-DZD9008 in Healthy Male SubjectsPHASE1 · COMPLETED · started Sep 24, 2021ClinicalTrials.gov NCT05159895 · fetched Nov 12, 2026
- A Study of DZD2269 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Jun 29, 2021ClinicalTrials.gov NCT04932005 · fetched Nov 12, 2026
- Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Apr 21, 2021ClinicalTrials.gov NCT04909242 · fetched Nov 12, 2026
- Assess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPCPHASE1 · TERMINATED · started Apr 12, 2021ClinicalTrials.gov NCT04634344 · fetched Nov 12, 2026
- DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast CancerPHASE1 · COMPLETED · started Sep 21, 2020ClinicalTrials.gov NCT04509596 · fetched Nov 12, 2026
- Pharmacokinetic and Mass Balance Study of Orally Administered [14C]-AZD4205 in Healthy Adult Male VolunteersPHASE1 · COMPLETED · started Jan 6, 2020ClinicalTrials.gov NCT04225208 · fetched Nov 12, 2026
- Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)PHASE1_PHASE2 · COMPLETED · started Sep 10, 2019ClinicalTrials.gov NCT04105010 · fetched Nov 12, 2026
- Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jul 9, 2019ClinicalTrials.gov NCT03974022 · fetched Nov 12, 2026
- A Study of AZD4205 in Healthy Adult SubjectsPHASE1 · COMPLETED · started Nov 12, 2018ClinicalTrials.gov NCT03728023 · fetched Nov 12, 2026